ARK Genomic Revolution ETF vs Invesco Solar ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.68, while Invesco Solar ETF trades at $53.79. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Invesco Solar ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | TAN | |
|---|---|---|
Sector | Sector/Thematic | Sector/Thematic |
52-Week High | $43.57 | $73.95 |
52-Week Low | $23.09 | $36.07 |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
TAN (Invesco Solar ETF) trades at $54.96, showing minimal daily movement with a 0.02% gain. The technical picture appears bearish with moving averages signaling selling pressure, though oscillators remain neutral. Recent news highlights both opportunities from AI-driven electricity demand and headwinds from regulatory challenges and supply chain costs. The ETF has transformed into a focused utility-scale solar play, benefiting from global clean energy investments while facing valuation concerns.
The outlook for TAN balances long-term growth potential from energy transition trends against near-term volatility. Investment opportunity lies in exposure to solar infrastructure benefiting from AI power demands, though risks include political uncertainty, Chinese supply chain tensions, and competitive pressure from nuclear energy. Current technical weakness suggests cautious entry points may be preferable for long-term investors.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →TAN is a thematic ETF that tracks the MAC Global Solar Energy Index. It provides targeted exposure to the global solar industry, including manufacturers of solar panels, installers, and component suppliers like Enphase and First Solar.
Read more on TAN →